Skip to main navigation

Menu

Skip to content

Investors

Alnylam

E-mail Alerts

Download Center

Print

Share this on:
Delicious
Digg
Facebook
LinkedIn
Twitter

Financial Information

FinancialMenu

Fundamentals
Financial Information
Quarterly Results
Key Ratios
Annual Reports

Here you will find a summary of Alnylam Pharmaceuticals, Inc.'s latest financial information.

Show all

Latest Earnings Release and 10-Q

Third Quarter Financial Results
Form 10-Q

Show all

Latest Annual Report and 10-K

2016 Annual Report
Form 10-K

Show all

Latest Proxy Statement

Latest Proxy Statement

Share Related Items

Market Capitalization (Mil)	$7,643.96
Shares Outstanding (Mil)	101.03
Shares Outstanding, Average (FY) (Mil)	90.55
Float (Mil)	89.54

Copyright Thomson Reuters Corporation

FY = Fiscal Year. MRQ = Most Recent Quarter. mil = Millions. TTM = Trailing Twelve Months.

Search

Recent Press Releases

View all releases

Dec 10,2018

Summary Toggle Alnylam Announces Settlement of Litigation with Silence Therapeutics
Dec 06,2018

Summary Toggle Alnylam Provides R&D Updates and Announces 2019 Product and Pipeline Goals at R&D Day
Nov 29,2018

Summary Toggle Alnylam to Webcast R&D Day

View all releases

: (Common):

Price:
Change (%):
Volume:
Data as of Copyright NASDAQ. Minimum 15 minutes delay

twitter
linkedin
youtube
rss

Copyright © 2018 Alnylam Pharmaceuticals, Inc. --- All Rights Reserved --- Glossary | Media Kit | Legal | Privacy Policy | Site Map